NCT01101191View on ClinicalTrials.gov

A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

January 31, 2008

Conditions
Healthy
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 80-mg tablet x 1 dose taken without food.

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 80-mg tablet x 1 dose taken without food.

Trial Locations (1)

96813

Covance Clinical Research Unit Honolulu, Honolulu

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01101191 - A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter